BIOCRYST PHARMACEUTICALS INC 10-Q filing
Filed 2025-11-04 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-048785
- Form type
- 10-Q
- CIK
- 0000882796
- Primary document
- https://www.sec.gov/Archives/edgar/data/882796/000162828025048785/bcrx-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOCRYST PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Cost Of Revenue | $9.6M | - | - |
| Operating Income | $80.6M | - | - |
| Net Income | $18.0M | - | - |
| Eps Basic | 0.09 | - | - |
| Eps Diluted | 0.08 | - | - |
| Cash And Equivalents | $84.1M | - | - |
| Total Assets | $446.4M | - | - |
| Total Liabilities | $834.3M | - | - |
| Shareholders Equity | $-387.9M | - | - |
| Operating Cash Flow | $55.4M | - | - |